Advanced search
Publication Cover
Expert Opinion on Biological Therapy Volume 4, 2004 - Issue 10
Submit an article Journal homepage
1,408
Views
7
CrossRef citations to date
0
Altmetric
Editorial

Transgenic plant-derived pharmaceuticals – the practical approach?

Akira Yano National Institute of Public Health, Department of Oral Health, Minami 2-3-6, Wako-shi, Saitama 351-0197, Japan. [email protected]
&
Masataka Takekoshi Tokai University School of Medicine, Department of Molecular Life Science, Isehara, Japan
Pages 1565-1568 | Published online: 23 Feb 2005

Bibliography

  • LANDER ES, LINTON LM, BIRREN B et al.: Initial sequencing analysis of the human genome. Nature (2001) 409(6822):860–921.
  • ABUIN A, HOLT KH, PLATT KA, SANDS AT, ZAMBROWICZ BP: Full-speed mammalian genetics: in vivo target validation in the drug discovery process. Trends Biotechnol (2002) 20(1):36–42.
  • SIMOENS C, VAN MONTAGU M: Genetic engineering in plants. Hum. Reprod. Update (1995) 1(6):525–542.
  • THE ROYAL SOCIETY OF LONDON et al.: Thansgenic Plants and World Agriculture. National Academy Press, Washington DC, USA (2000):1–40.
  • ••Important report under the auspices of theinternational science societies.Can be accessed at http://books.nap.edu/ html/transgenic/
  • VASIL IK: The science and politics of plant biotechnology - a personal perspective. Nat. Biotechnol (2003) 21 (8) :849–851.
  • FISCHER R, TWYMAN PM,SCHILLBERG S: Production of antibodiesin plants and their use for global health. Vaccine (2003) 21(7-8):820–825.
  • GARBER K: Biotech industry faces new bottleneck. Nat. Biotechnol (2001) 19(3):184–185.
  • BAKKER H, BARDOR M,MOLTHOFF JW et al: Galactose-extended glycans of antibodies produced by transgenic plants. Proc. Natl. Acad. Sci. USA (2001) 98(5)2899–2904.
  • SRIRAMAN R, BARDOR M, SACK M et al.: Recombinant anti-hCGantibodies retained in the endoplasmic reticulum of transformed plants lack core-xylose and core-a(1,3)-fucose residues. Plant Biotechnol J. (2004) 2 (4) :279–288.
  • DECKER E, RESKI R: The moss bioreactor. Curr. Opin. Plant Biol. (2004) 7(2):166–170.
  • YANO A, MAEDA F, TAKEKOSHI M: Transgenic tobacco cells producing the human monoclonal antibody to hepatitis B virus surface antigen. J. Med. Virol (2004) 73 (2):208–215.
  • BEASLEY PR, HWANG LY, STEVENS CE et al.: Efficacy of hepatitis B immune globulin for perinatal transmission of the hepatitis B virus carrier state: Final report of a randomized double-blind, placebo-controlled trial. Hepatology (1983) 3(2):135–141.
  • MULLER R, GUBERNATIS G, FARLE M et al.: Liver transplantation in HBs antigen (HBsAg) carriers: Prevention of hepatitis B virus (HBV) recurrence by passive immunization. Hepatology (1991) 13 (1):90–96.
  • GALUN E, EREN R, SAFADI R et al.: Clinical evaluation (Phase I) of a combination of two human monoclonal antibodies to HBV: safety and antiviral properties. Hepatology (2002) 35 (3):673–679.
  • KELLER MA, STIEHM ER: Passive immunity in prevention and treatment of infectious diseases. Clin. Microbial. Rev (2000) 13(4):602–614.
  • PETERSON RK, ARNTZEN CJ: On risk and plant-based biopharmaceuticals. Trends Biotechnol (2004) 22(2):64–66.
  • KAPUSCINSKI AR, GOODMAN RM, HANN SD et al.: Making 'safety first' a reality for biotechnology products. Nat. Biotechnol (2003) 21(0599–601.
  • MASCIA PN, FLAVELL RB: Safe and acceptable strategies for producing foreign molecules in plants. Carr: Opin. Plant Biology (2004) 7(2):189–195.
  • GUIDANCE FOR INDUSTRY: Drugs, biologics, and medical devices derived from bioengineered plants for use in humans and animals, draft guidance. Docket No. 02D-0324, CBER 200134. Fed. Reg. (2002) 67:57828–57829.
  • NO AUTHORS LISTED: Drugs in crops — the unpalatable truth. Nat. Biotechnol (2004) 22(2):133.
  • STEWART CN JR, HALFHILL MD, WARWICK SI: Transgene introgression from genetically modified crops to their wild relatives. Nat. Rev Genet. (2003) 4(10):806–817.
  • HINO A: Safety assessment and public concerns for genetically modified food products: the Japanese experience. Toxicol Pathol (2002) 30(1):126–128.
  • SMYTH S, PHILLIPS PW: Labeling to manage marketing of GM foods. Trends Biotechnol (2003) 21(9):389–393.
  • RUTTAN VW: The transition to agricultural sustainability. Proc. Natl. Acad. Sci. USA (1999) 96(11):5960–5967.
  • KATE RW, PARRIS TM: Long-term trends and a sustainability transition. Proc. Natl. Acad. Sci. USA (2003) 100(14):8062–8067.
  • PILATE G, GUINEY E, HOLT K et al: Field and pulping performances of transgenic trees with altered lignification. Nat. Biotechnol (2002) 20(6):607–612.
  • YE X, AL-BABILI S, KLOTI A et al: Engineering the provitamin A (I3-carotene) biosynthetic pathway into (carotenoid-free)rice endosperm. Science (2000) 287(5451)303–305.
  • RASKIN I, RIBNICKY DM, KOMARNYTSKY S et al: Plants and human health in the twenty-first century. Trends Biotechnol (2002) 20(12):522–531.
  • MA JK, DRAKE PM, CHRISTOU P: Theproduction of recombinant pharmaceutical proteins in plants. Nat. Rev Genet. (2003) 4(10):794–805.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.